Patent Assignment
Reel/Frame 018680/0524
Division of Company
Recorded: 2006-12-27
Pages: 8
Assignor
EISAI CO., LTD.
Executed: 2006-12-22
Assignee
EISAI R & D MANAGEMENT CO., LTD.
6-10 KOISHIKAWA 4-CHOME, BUNKYO-KU, TOKYO, 112-8088, JAPAN
Covered Properties
(5)
Use of compounds having gip activity for the treatment of disorders associated with abnormal loss of cells and/or for the treatment of obesity
Application:
10/518,159 →
Publication:
US 2005/0245441
Neurocyte protective agent
Application:
10/560,179 →
Publication:
US 2007/0021397
Herg Channel-Expressing Cell
Therapeutic agent for Abeta related disorders
Application:
11/111,504 →
Publication:
US 2006/0241038
Use of Sulfonamide-Including Compounds in Combination with Angiogenesis Inhibitors
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 18, 2005
From: NYBERG, JENNY; ERIKSSON, PETER
To: EISAI CO., LTD.
Reel/Frame 016726/0737 →
Assignment of Assignor's Interest
Sep 6, 2005
From: WATANABE, HIDEKI; BERNIER, FRANCOIS; MIYAGAWA, TAKEHIKO
To: EISAI CO., LTD.
Reel/Frame 016965/0169 →
Assignment of Assignor's Interest
Dec 9, 2005
From: AKASOFU, SHIGERU; KIMURA, MANAMI
To: EISAI CO., LTD.
Reel/Frame 017360/0978 →
Assignment of Assignor's Interest
Feb 22, 2006
From: OWA, TAKASHI; OZAWA, YOICHI; SEMBA, TARO
To: EISAI CO., LTD.
Reel/Frame 017279/0696 →
Assignment of Assignor's Interest
Jul 11, 2006
From: YOSHINAGA, TAKASHI; ARAI, TORU
To: EISAI CO., LTD.
Reel/Frame 017909/0951 →